German research institute offers to develop scalable, microfluidic and tailored nanoformulations including lipid/polymer/peptide/magnetic nanoparticles-based platform for nucleic acid delivery: Open for EU consortia (Horizon Europe, EIC Pathfinder, Eureka)
A German research institute specialising in nanomedicine and process engineering seeks to join an R&D consortium to develop advanced, customisable mRNA nanoformulations. The institute offers a microfluidic-assisted, scalable platform enabling high-throughput screening and optimisation of lipid/polymer-based delivery systems. Collaboration is targeted within Horizon Europe Cluster 1: Health, EIC Pathfinder, or Eureka funding frameworks.